Small molecule therapeutics for brain disorders

脑部疾病的小分子疗法

• 批准号: nhmrc : GNT1154692
• 负责人: Prof Michael Kassiou
• 金额: $ 78.54万
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/small-molecule-therapeutics-brain-disorders/1349153
• 关键词: Small; molecule; therapeutics; brain; disorders

I will establish and advance the field of CNS drug discovery in Australia. I will train the next generation of researchers and research leaders with the breadth of skills to enable efficient and cost-effective drug discovery. I will deliver new drug candidates for CNS diseases by coordinating a greater part of the drug development pathway. I will lead research translation through multidisciplinary collaboration and to focus on interrelated features that are central to CNS diseases.

我将在澳大利亚建立和推进中枢神经系统药物发现领域。我将培养下一代研究人员和研究领导者，使他们具备广泛的技能，从而实现高效和具有成本效益的药物发现。我将通过协调大部分药物开发途径，为CNS疾病提供新的候选药物。我将通过多学科合作领导研究翻译，并专注于中枢神经系统疾病的相关特征。